MCL1 and cancer: Hits for the PF-NSC-like program included Wnt-signaling regulator LGR5 and the anti-apoptotic gene MCL1, as well as the cancer stemness-associated genes as potential druggable vulnerabilities (Xu et al., 2019) (Figure 3H and Table S7).